FDA Policy for REMS Reqmts during COVID-19
Health Care, Pharma Industry, Strategic Planning
FDA is issuing this guidance to communicate its temporary policy for certain risk evaluation and mitigation strategies (REMS) requirements for the duration of the coronavirus pandemic public health emergency.
Read the Policy now
Related Education Resources.
All ResourcesCarol Jarvis – European Knowledge Forum Patient Testimonial 2022
Topic: Conference
Video
Members
Leadership Lessons for Re-Entry
Topics: Leadership, Management
Webinar
Free
EAP 105: Expanded Access Logistics
Topics: Additional Concepts, Closeout, EAP, Execution, Forecasting / Planning
Presentation
Members
